Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Chronic HepatitiRockstrohs and HIV: Implications For Care - Jürgen Rockstroh, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Treatment of HCV in HIV - Mark Sulkowski, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

ESLD a Guide for HIV Physicians - Marion Peters, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

What's new in HCV/HIV coinfection therapy - Mark Sulkowski, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Will DAA drug-drug interactions matter in the future - David Back, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Viral hepatitis and pregnancy - Eleni Nastouli

Slideset

HIV

Viral Hepatitis and Liver Disease

Cost per cure-is it worth it? - Douglas Dieterich, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Towards more affordable HCV therapy - Andrew Hill, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Management of HCV: Pre and Post transplant - Kosh Agarwal, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

ESLD and its complications - Massimo Puoti, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

HBV - Current and Future Treatment paradigms - Patrick Kennedy, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Viral Hepatitis and Malignancy - David Pinato, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Delta Hepatitis-New approaches to therapy - Vincent Soriano, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

26_Dieterich

Slideset

HIV

Viral Hepatitis and Liver Disease

Recreational drug use in the HIV population - David Stuart

Slideset

HIV

Viral Hepatitis and Liver Disease

Debate: HIV is no special population anymore - Sanjay Bhagani, BSc, FRCP

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinical Relevant Drug Interactions - Saye Khoo, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Transmission of (primary) Drug resistance - Charles Boucher, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Translation to Clinical Management - Jonathan Schapiro, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Does hepatitis D in HBV/ HIV co-infected patients affect liver function? | J. Kozlowska #1

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Antioxidant response in patients with chronic hepatitis B or C. | K. Wójcik-Cichy #2

Slideset

HIV

Viral Hepatitis and Liver Disease

State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Chronic Hepatitis C Treatment In Patients Coinfected With HCV/HIV | S. Fedorchenko #4

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Toll-like receptor 4 polymorphism influence on the clinical course of chronic hepatitis C in HIV-infected patients | T. Kyrychenko #5

Slideset

HIV

Viral Hepatitis and Liver Disease

Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1. | S. Mauss #6

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Endothelial dysfunction and its influence on the development of subclinical atherosclerosis in HIV/HCV positive patients | K. Barska #10

Slideset

HIV

Viral Hepatitis and Liver Disease

Abstract: Evaluation of early cerebral alterations in the course of HIV and HCV infection using perfusion MR imaging: is the hepatitis C virus more dangerous for the brain? | J. Bladowska #8

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Poland | Milosz Parczewski, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

AbbVie

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Ukraine | Larisa Moroz, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Romania | Adrian Streinu Cercel, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Local Situation in Turkey | Cihan Yurdaydin, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Management of End-stage Liver Disease | Massimo Puoti, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

Slideset

HIV

Viral Hepatitis and Liver Disease

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Management of Drug Drug Interactions | David Back, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Inhibition of HIV Integrase: Virology and Resistance | Charles Boucher, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Clinically Relevant Drug Interactions | Saye Khoo

Slideset

HIV

Viral Hepatitis and Liver Disease

Integrase Inhibitors: Clinical Considerations | Jonathan Schapiro, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

HCV - The Virus - Geoffrey Dusheiko, MD, MB, BCh

Acute Hepatitis C - Christoph Boesecke, MD

Non Hepatic Complications - Kenneth Sherman, MD, PhD

Chronic HepatitiRockstrohs and HIV: Implications For Care - Jürgen Rockstroh, MD

Treatment of HCV in HIV - Mark Sulkowski, MD

ESLD a Guide for HIV Physicians - Marion Peters, MD

What's new in HCV/HIV coinfection therapy - Mark Sulkowski, MD

Will DAA drug-drug interactions matter in the future - David Back, PhD

Viral hepatitis and pregnancy - Eleni Nastouli

Cost per cure-is it worth it? - Douglas Dieterich, MD

Towards more affordable HCV therapy - Andrew Hill, MD

Management of HCV: Pre and Post transplant - Kosh Agarwal, MD

ESLD and its complications - Massimo Puoti, MD

Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD

NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD

HBV - Current and Future Treatment paradigms - Patrick Kennedy, MD

Viral Hepatitis and Malignancy - David Pinato, MD

Delta Hepatitis-New approaches to therapy - Vincent Soriano, MD, PhD

26_Dieterich

Recreational drug use in the HIV population - David Stuart

Debate: HIV is no special population anymore - Sanjay Bhagani, BSc, FRCP

Clinical Relevant Drug Interactions - Saye Khoo, MD, PhD

Transmission of (primary) Drug resistance - Charles Boucher, MD, PhD

Translation to Clinical Management - Jonathan Schapiro, MD

Abstract: Does hepatitis D in HBV/ HIV co-infected patients affect liver function? | J. Kozlowska #1

Abstract: Antioxidant response in patients with chronic hepatitis B or C. | K. Wójcik-Cichy #2

State of the Art Treatment of Hepatitis B | Maria Buti, MD, PhD

Abstract: Chronic Hepatitis C Treatment In Patients Coinfected With HCV/HIV | S. Fedorchenko #4

Abstract: Toll-like receptor 4 polymorphism influence on the clinical course of chronic hepatitis C in HIV-infected patients | T. Kyrychenko #5

Acute Hepatitis C Infection | Christoph Boesecke, MD, PhD

Abstract: Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1. | S. Mauss #6

Abstract: Endothelial dysfunction and its influence on the development of subclinical atherosclerosis in HIV/HCV positive patients | K. Barska #10

Abstract: Evaluation of early cerebral alterations in the course of HIV and HCV infection using perfusion MR imaging: is the hepatitis C virus more dangerous for the brain? | J. Bladowska #8

Local Situation in Poland | Milosz Parczewski, MD, PhD

AbbVie

Local Situation in Ukraine | Larisa Moroz, MD, PhD

Local Situation in Romania | Adrian Streinu Cercel, MD, PhD

Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhD

Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhD

Local Situation in Turkey | Cihan Yurdaydin, MD

Management of End-stage Liver Disease | Massimo Puoti, MD

State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCP

An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe | Mojca Maticic, MD, PhD

Natural History of HCV Infection | Krzysztof Simon, MD, PhD

Management of Drug Drug Interactions | David Back, PhD

Inhibition of HIV Integrase: Virology and Resistance | Charles Boucher, MD, PhD

Clinically Relevant Drug Interactions | Saye Khoo

Integrase Inhibitors: Clinical Considerations | Jonathan Schapiro, MD

Epidemiology of Hepatitis B in Central and Eastern Europe | Adrian Streinu Cercel, MD, PhD